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Abstract
Paediatric non-alcoholic fatty liver disease has increased in parallel with childhood obesity. Dietary habits, particularly products rich in sugars, may
influence both hepatic fat and insulin resistance (homeostatic model assessment for insulin resistance (HOMA-IR)). The aim of the study was to
examine the association of the consumption of foods and food components, dairy desserts and substitutes (DDS), sugar-sweetened beverages
(SSB), as well as total and added sugars, with hepatic fat and HOMA-IR. Dietary intake (two non-consecutive 24h-recalls), hepatic fat (MRI) and
HOMA-IR were assessed in 110 overweight/obese children (10·6 (SD 1·1) years old). Linear regression analyses were used to examine the
association of dietary intake with hepatic fat and HOMA-IR adjusted for potential confounders (sex, age, energy intake, maternal educational level,
total and abdominal adiposity and sugar intake). The results showed that there was a negative association between cereal intake and hepatic fat
(β=–0·197, P< 0·05). In contrast, both SSB consumption (β=0·217; P= 0·028) and sugar in SSB (β= 0·210, P= 0·035), but not DDS or sugar in
DDS or other dietary components, were positively associated with hepatic fat regardless of potential confounders including total sugar intake. In
conclusion, cereal intake might decrease hepatic fat, whereas SSB consumption and its sugar content may increase the likelihood of having hepatic
steatosis. Although these observations need to be confirmed using experimental evidence, these results suggest that healthy lifestyle intervention
programs are needed to improve dietary habits as well as to increase the awareness of the detrimental effects of SSB consumption early in life.
Key words: Hepatic steatosis: Childhood obesity: Homeostatic model assessment for insulin resistance: Dietary intake:
Sugar-sweetened beverages
In recent years, the incidence of paediatric non-alcoholic fatty
liver disease (NAFLD) has increased worldwide in parallel with
childhood obesity rates and, therefore, constitutes an emerging
global health concern(1). NAFLD is one of the most common
causes of liver disease among children and adolescents(2) and
consists of the accumulation of lipids within the hepatocytes in
the absence of excess alcohol consumption(3). This pathological
disorder is strongly associated with insulin resistance and dys-
lipidaemia and, therefore, it is considered to be the hepatic
manifestation of the metabolic syndrome(4,5).
Diet and other lifestyle determinants seem to modulate
hepatic steatosis development and progression(6). For instance,
western dietary habits(7) in both normal weight and overweight/
obese adolescents, as well as energy intake in children(8) or
dietary sugar intake such as fructose or sucrose in adults(9), may
have an influence on hepatic fat content and other cardio-
metabolic risk factors(10,11).
Sugar-sweetened beverages (SSB) are the main source of
dietary added sugars among children and adolescents, repre-
senting around 10–15% of their dietary energy intake(12,13).
Abbreviations: DDS, dairy desserts and substitutes; HOMA-IR, homeostatic model assessment for insulin resistance; NAFLD, non-alcoholic fatty liver disease;
SSB, sugar-sweetened beverages.
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Along with the increase in childhood obesity and hepatic
steatosis, SSB consumption has also risen in the last years(12).
In this context, a systematic review and meta-analysis reported
higher risk of NAFLD assessed by abdominal ultrasound or
liver biopsy in patients consuming SSB(14). Other studies have
also shown association of SSB consumption with adiposity,
type 2 diabetes, the metabolic syndrome and CVD risk
factors(15).
Dairy desserts and substitutes (DDS) are other common
dietary sugar sources among children since they are often fla-
voured and sugar sweetened(9,16). Nevertheless, the sugar
added in DDS seems not to play such a detrimental role in
cardiometabolic health in comparison with sugar from SSB(17).
In contrast, the intake of other food groups and dietary com-
ponents such as fruits and vegetables(18), dairy products(19) and
fibre(20,21) may have a protective role against the metabolic
syndrome and hepatic fat accumulation. However, the majority
of the studies examining the association of dietary intake with
hepatic steatosis are conducted in adolescents(7,18) and adult
populations(22). Hence, there are few studies examining the
relationship between dietary habits and liver health(23,24) or
insulin resistance(25) in overweight and obese children, and, to
the best of our knowledge, none of these studies measured
hepatic fat content by MRI, which is considered to be the gold
standard.
We hypothesised that the intake of products rich in added
sugars, such as SSB consumption, would be associated with
higher hepatic fat accumulation, whereas no such association
would be observed between DDS and hepatic fat content.
Likewise, fibre or fibre-rich foods would be beneficial in the
prevention of hepatic steatosis and insulin resistance.
Therefore, the aims of the present study were to examine
(i) the association of the consumption of dietary foods and
components on hepatic fat content and insulin resistance
(homeostatic model assessment for insulin resistance (HOMA-
IR)) and (ii) the influence of SSB and DDS, as well as their sugar
content, on hepatic fat content and insulin resistance in over-
weight/obese children.
Methods
Study participants and design
The Prevention of Diabetes in Kids (PREDIKID) study is a
randomised controlled trial (ClinicalTrials.gov ID:
NCT03027726) examining the effect of a family-based inter-
vention program(26) on diabetes risk of overweight/obese
children. The study protocol was approved by the Ethic Com-
mittee of Clinical Investigation of Euskadi (PI2014045) and the
research was conducted according to the Declaration of
Helsinki. Participants were recruited from the Pediatric Endo-
crinology Unit of the University Hospital of Araba and Primary
Care Clinics from Vitoria-Gasteiz and surroundings (North of
Spain) in 2017. The main outcome of the trial was insulin
resistance(26), whereas the primary outcomes for this sub-study
were hepatic fat content and insulin resistance. The inclusion
criteria were (1) to be aged between 8 and 12 years, (2) to
have overweight or obesity and (3) to meet the international
criteria for classification of type 2 diabetes risk. All participants’
parents or legal guardians signed an informed written consent
for their children in order to be enrolled in the study. The
present cross-sectional study includes baseline data of 110
children (10·6 (SD 1·1) years old, 53·1% girls) with overweight or
obesity participating in the PREDIKID study who had dietary
intake and hepatic fat content data.
Anthropometry
Height (SECA 220) and body weight (SECA 760) were mea-
sured barefoot according to standard protocols, and waist
circumference was measured with a non-elastic tape (SECA
201) following international recommendations. BMI was
calculated as body weight divided by height squared (kg/
m2) and, thereafter, children were classified as having
overweight or obesity according to World Obesity Federa-
tion criteria(27). All the anthropometric measurements were
carried out by the same trained researcher to avoid inter-
personal variability bias. Pubertal stage was directly exam-
ined by a paediatrician and classified according to Tanner &
Whitehouse(28) criteria.
Body composition
Dual-energy X-ray absorptiometry (QDR 4500W; Hologic) was
used to evaluate total and abdominal adiposity. Abdominal
adiposity was measured by determining three abdominal sec-
tions as described elsewhere(29).
Hepatic fat
Hepatic fat content was measured by MRI (MAGNETOM
Avanto; Siemens Healthcare) with phased-array surface coil and
a spine array coil equipment. This was provided by the work-
in-progress software package by Siemens Medical System
(version syngo.MR B17A). Briefly, two different three-dimen-
sional gradient-echo sequences in breath-hold and six-echo
acquisition with advanced signal analysis were used for hepatic
fat quantification and estimation, respectively, as reported
elsewhere(30). According to the literature, liver proton density
fat fraction estimated by MRI correlates well with histologic
steatosis grade in children(31), and therefore MRI is considered a
non-invasive and accurate method to detect hepatic steatosis in
paediatric population(32).
In accordance with previous studies, the cut-off value of
hepatic fat content established for categorising children with
and without hepatic steatosis was 5·5%(33,34). Therefore, chil-
dren with a hepatic fat ≥5·5% were considered as having
hepatic steatosis, whereas children with <5·5% hepatic fat
accumulation as not having hepatic steatosis.
Insulin resistance
Insulin resistance was determined by calculating HOMA-IR
using fasting blood glucose and insulin values with the fol-
lowing formula: (insulin (µU/ml× glucose (mmol/l))/22·5)(35).
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Blood sample collection details have been published
elsewhere(30).
Dietary intake assessment
Dietary intake was evaluated, by trained nutritionists, as the
mean of two non-consecutive 24 h-recalls during a time span of
a week. Children reported, with help of their parents, all the
foods and beverages consumed the day before the interview.
Pictures of food servings were used to help the participants to
estimate food intake. Nutritional composition data was obtained
by EasyDiet software. Thereby, energy intake and macro- and
micro-nutritional composition data from both interviewed
days was obtained. Regarding the food groups, each dietary
recall was examined thoroughly, and thereafter, the food con-
sumed was classified into the different food groups so as to
obtain the daily food-group intake. Afterwards, the mean
consumption of the dietary components consumed in both
interviewed days was computed.
Fruits and vegetables were analysed together. Detailed
information about foods included in each food category and
explanation about each term is available in online Supple-
mentary Table S1. Participants were asked to report product
brands, particularly for SSB and DDS, to obtain detailed nutri-
tional composition data, that is, sugar and energy content of
each food and beverage. SSB consumption included SSB, while
low- or non-energetic beverages were excluded due to the
reduction of sugar and replacement for artificial non-energetic
sweeteners. DDS were considered milk-derived products with
added sugar when its sugar content was ≥6 g/100 g product.
The current sugar cut-off value was established based on the
natural lactose content of dairy products, assuming that dairy
products with higher sugar content may have sugar added in
their composition. Also, all dairy product substitutes such as
soya-, oat- or almond-beverages were included in DDS, but
no cut-off value for sugar content was used since they are not
milk-based.
Furthermore, total added sugar was calculated by removing
the sugar amount in natural sugar sources such as fruits and
dairy products from total dietary sugar intake.
Physical activity
Accelerometry was used as an objective measurement of total
physical activity (wActisleep-BT and wGT3X-BT; ActiGraph).
All participants had to wear an accelerometer on the non-
dominant wrist during a week. Euclidean Norm Minus One was
used to quantify the acceleration related to the movement
registered expressed in mg using R software (version 3.1.2,
www.cran.r-project.org) with the GGIR package (version 1.5-
12, https://cran.r-project.org/web/packages/GGIR/).
Statistical analysis
As the variables did not show a normal distribution, non-
parametrical Mann–Whitney U tests were used to examine the
differences in continuous variables (i.e. biological character-
istics and dietary intake) between children with and without
hepatic steatosis, whereas the χ2 test was used for categorical
variables. Linear regression analyses were used to examine the
association between dietary components (independent vari-
ables) and hepatic fat content and insulin resistance (dependent
variables). Potential confounders such as sex, age, energy
intake and maternal educational level (model 1) and addition-
ally body fat percentage (model 2) or abdominal adiposity
(model 3) and dietary simple sugar intake (model 4) were used
as covariates in the analyses. Variables with a non-normal dis-
tribution were logarithmically transformed for linear regression
analyses. Sensitivity analyses were performed in dietary vari-
ables and hepatic fat content analysis adjusting additionally for
HOMA-IR, physical activity and parental BMI. Collinearity
diagnosis tests were also performed between dietary factors to
examine whether they were related to one another. Statistical
analyses were carried out with the statistical software SPSS
version 20.0 (SPSS Inc.) with the significance level of α= 0·05.
Results
Biological characteristics and dietary intake of participants with
and without hepatic steatosis are shown in Table 1. The pro-
portion of children with hepatic steatosis was 36·4%. Children
with hepatic steatosis had significantly higher BMI z-score
(P< 0·03), waist circumference (P< 0·01), total and abdominal
adiposity (P< 0·01), hepatic fat content (P< 0·001) and HOMA-
IR (P< 0·01) compared to children without hepatic steatosis.
Likewise, the percentage of children with obesity was higher in
the group with hepatic steatosis (P< 0·03), while age, sex, high
maternal educational level, parental obesity and diabetes and
total physical activity were similar between both groups
(P> 0·05), non-Caucasian ethnicity was higher among children
with hepatic steatosis (P< 0·03). In contrast, no significant dif-
ferences were observed in the intake of macronutrients, simple
sugars, added sugars, fibre, cereals, fruits and vegetables,
legumes, nuts, dairy products, fish and shellfish and meat and
meats products between children with and without hepatic
steatosis (P> 0·1). The consumption of SSB and the sugar
content of SSB tended to be higher in children with hepatic
steatosis than in their peers without hepatic steatosis (P< 0·1).
Table 2 shows the associations of dietary components with
hepatic fat content and insulin resistance. A negative association
was observed between cereal intake and hepatic fat content
regardless of sex, age, energy intake and maternal educational
level (P< 0·02, model 1). This association was diminished, but
remained significant, when both total (model 2) and abdominal
fat (model 3) were entered into the model (P< 0·05). No sta-
tistically significant associations were found between the rest of
dietary components and hepatic fat content and insulin resis-
tance in overweight/obese children.
The associations of SSB and DDS intake and the intake of
their sugar contents with hepatic fat and HOMA-IR are shown in
Table 3. The results showed that both SSB consumption and the
intake of sugar from SSB were significantly associated with
hepatic fat content regardless of sex, age, energy intake and
maternal educational level (P< 0·02, model 1). These relation-
ships were still significant when either body fat percentage or
1160 L. Arenaza et al.
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abdominal fat were included into the model (P< 0·02, models 2
and 3). Interestingly, the association of SSB consumption and
the intake of sugar from SSB with hepatic fat content remained
statistically significant even after further adjustment for total
simple sugar intake (P< 0·05, model 4). In a sensitivity (addi-
tional adjustment) analysis with insulin resistance (β= 0·212,
P= 0·036 and β= 0·204, P= 0·045 for SSB and sugar from SSB,
respectively), physical activity (β= 0·217, P= 0·032 and
β= 0·206, P= 0·043 for SSB and sugar from SSB, respectively)
and parental BMI (β= 0·207, P= 0·037 and β= 0·199, P= 0·047
for SSB and sugar from SSB, respectively) this association
remained statistically significant. Continuous logistic regression
was performed to analyse the effect of SSB consumption in
children with and without hepatic steatosis (sex, age, maternal
educational level and energy intake adjustments); and even
though it was not statistically significant, a trend to signification
was observed (OR 1·003, 95% CI 1·000, 1·007, P= 0·051). On
the contrary, no significant relationships were observed
between DDS consumption and sugar from DDS with hepatic
fat content in overweight/obese children (P> 0·05). Neither SSB
nor DDS consumption were associated with insulin resistance
(P>0·05). No collinearity was found between dietary factors.
Discussion
The present study examined the influence of several food
groups and dietary components on hepatic fat content and
Table 1. Biological characteristics and dietary intake of participants with and without hepatic steatosis of the children participating in the Prevention of
Diabetes in Kids (PREDIKID) study
(Mean values and standard deviations)
Children with hepatic steatosis (n 40) Children without hepatic steatosis (n 70)
n Mean SD n Mean SD P
Age (years) 40 10·5 1·1 70 10·6 1·1 0·485
Girls 40 70 0·563
n 20 39
% 50 55·7
BMI z-score 40 0·29 1·1 70 –0·16 0·9 0·028*
Obese 40 70 0·007*
n 30 34
% 75 48·6
Waist circumference (cm) 40 82·3 7 70 76·7 6·6 <0·001*
Body fat (%) 40 41·2 4·2 69 38·4 4·6 0·005*
Abdominal fat (kg) 40 3 1·1 69 2·3 8·4 <0·001*
Hepatic fat (%) 40 9·2 4·9 70 3·6 1 <0·001*
HOMA-IR 39 3·0 1·3 69 2·3 1 0·005*
High maternal educational level 39 70 0·173
n 12 16
% 30·8 22·5
Parental obesity 40 70 0·471
n 11 15
% 27·5 21·4
Parental diabetes 39 70 0·686
n 3 4
% 7·5 5·7
Non-Caucasian ethnicity 38 69 0·029*
n 10 7
% 25 10
Total physical activity (mg) 38 61·7 14·6 65 65·9 17 0·286
Energy intake (kJ/d) 40 7878 1498 70 7460 1858 0·131
Carbohydrates (g/d) 40 196 60 70 190 50 0·737
Fat (g/d) 40 86 25 70 79 26 0·148
Proteins (g/d) 40 79 19 70 76 20 0·437
Fibre (g/d) 40 14 5 70 14 7 0·921
Cereals (g/d) 40 92 53 70 105 48 0·184
Fruits and vegetables (g/d) 40 251 183 70 224 148 0·686
Legumes (g/d) 40 12·7 15·8 70 14·3 20·8 0·799
Nuts (g/d) 40 2 6·5 70 3 9 0·697
Dairy products (g/d) 40 347 188 70 321 134 0·725
Fish and shellfish (g/d) 40 47 57 70 34 45 0·260
Meat and meat products (g/d) 40 107 70 70 98 76 0·389
Simple sugars (g/d) 40 89 37 70 82 26 0·445
Added sugar (g/d) 40 60 31 70 51 22 0·146
SSB (ml/d) 40 117 169 70 53 91 0·069
Sugar from SSB (g/d) 40 9·8 14·7 70 4·6 8·0 0·094
DDS (g/d) 40 81 77 70 85 93 0·839
Sugar from DDS (g/d) 40 10·6 10 70 10·8 12·0 0·739
HOMA-IR, homeostatic model assessment for insulin resistance; SSB, sugar-sweetened beverages; DDS, dairy desserts and substitutes.
* P<0·05.
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insulin resistance among pre-adolescent overweight/obese
children. The main findings were that cereal intake was nega-
tively associated with hepatic fat content but not with insulin
resistance, whereas the rest of the food groups and macro-
nutrients were associated neither with hepatic fat content nor
with insulin resistance. Moreover, SSB consumption and sugar
from SSB were positively associated with hepatic fat accumu-
lation, but not with insulin resistance. In contrast, we did not
observe any significant relationships between DDS and hepatic
fat content or insulin resistance among overweight/obese chil-
dren aged 8–12 years.
Almost half of the children in the study (36·4% of the parti-
cipants) presented with hepatic steatosis. It is well-known that
excess adiposity increases the risk of having NAFLD(36). Our
findings about prevalence are in agreement with those from
two previous studies. One of them reported that whilst the
prevalence of paediatric hepatic steatosis is lower than 10% in
general population, the prevalence among children with
obesity can reach 80%(37). According to other study, the
prevalence of NAFLD in children with normal weight was 2·6%,
which increased to 20–77% among obese children and ado-
lescents (38). Nevertheless, it should be pointed out that the
range of prevalence might vary depending on the diagnosis
method used for measuring hepatic fat content. In this study,
hepatic fat content was measured by MRI, which is a more
accurate method compared to ultrasound, and in fact, it has
been considered a non-invasive appropriate alternative for
paediatric population(33). Furthermore, and in line with other
studies(34), ethnic differences between Hispanic, Black and
White population were observed in the prevalence of hepatic
steatosis. Regarding body composition, children with hepatic
steatosis had higher values of waist circumference as well as
total and abdominal adiposity compared to children without
hepatic steatosis. On the contrary, participants with hepatic
steatosis did not show higher values of BMI, which demon-
strates the limitations of using BMI as a proxy of body fatness in
children(39). Accordingly, based on the strong association
between abdominal adiposity and hepatic steatosis, Alisi
et al.(40) reported that abdominal obesity is more powerful than
BMI in predicting hepatic steatosis.
Overall, we found only few differences in dietary intake
variables between children with and without hepatic steatosis.
In contrast to our results, a previous study reported that ado-
lescents with hepatic steatosis had higher intake of total fat and
Table 2. Association of dietary energy and macronutrient intake, and other dietary components with hepatic fat content and insulin resistance in overweight/
obese children*
Hepatic fat content (%) HOMA-IR
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
β P β P β P β P β P β P
Energy (kJ/d) 0·033 0·740 – – – – 0·068 0·487 – – – –
Carbohydrates (g/d) –0·016 0·919 0·017 0·913 0·007 0·965 0·048 0·761 0·112 0·452 0·098 0·477
Fat (g/d) 0·034 0·838 0·041 0·796 0·044 0·779 –0·026 0·874 –0·063 0·693 –0·064 0·665
Proteins (g/d) –0·017 0·907 –0·097 0·477 –0·084 0·533 –0·041 0·772 –0·092 0·485 –0·066 0·591
Fibre (g/d) –0·118 0·261 –0·152 0·132 –0·157 0·114 0·052 0·620 0·037 0·706 0·028 0·763
Cereals (g/d) –0·254 0·013† –0·211 0·036† –0·197 0·048† 0·003 0·979 0·062 0·530 0·091 0·328
Fruits and vegetables (g/d) 0·028 0·771 0·044 0·638 0·062 0·501 0·063 0·511 0·080 0·381 0·116 0·173
Dairy products (g/d) 0·085 0·384 0·125 0·190 0·095 0·322 –0·073 0·454 –0·018 0·849 –0·085 0·334
Fish and shellfish (g/d) 0·152 0·114 0·112 0·230 0·103 0·263 0·110 0·250 0·079 0·389 0·069 0·422
Meat and meat products (g/d) –0·007 0·949 –0·008 0·939 0·001 0·995 –0·076 0·492 –0·134 0·207 –0·119 0·230
HOMA-IR, homeostatic model assessment for insulin resistance.
* Model 1: adjusted for sex, age, energy intake and maternal educational level; model 2: model 1 additionally adjusted for body fat percentage; model 3: model 2 additionally
adjusted for abdominal adiposity.
† P<0·05.
Table 3. Associations of sugar-sweetened beverages (SSB) and dairy desserts and substitutes (DDS) consumption as well as their sugar content with
hepatic fat content and insulin resistance (homeostatic model assessment for insulin resistance (HOMA-IR)) in overweight/obese children*
Hepatic fat content (%) HOMA-IR
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
β P β P β P β P β P β P β P β P
SSB (g/d) 0·263 0·008† 0·250 0·009† 0·243 0·010† 0·217 0·028† 0·108 0·276 0·102 0·282 0·085 0·336 0·094 0·318
Sugar from SSB (g/d) 0·254 0·011† 0·243 0·011† 0·237 0·012† 0·210 0·035† 0·106 0·292 0·100 0·298 0·085 0·340 0·094 0·322
DDS (g/d) –0·051 0·612 –0·067 0·498 –0·048 0·621 –0·081 0·412 –0·054 0·585 –0·128 0·184 –0·092 0·309 –0·096 0·299
Sugar from DDS (g/d) –0·037 0·715 –0·053 0·593 –0·036 0·715 –0·070 0·483 –0·061 0·540 –0·135 0·163 –0·099 0·274 –0·104 0·263
Simple sugar (g/d) 0·131 0·270 0·171 0·135 0·179 0·112 – – –0·053 0·648 –0·013 0·904 0·004 0·969 – –
Added sugar (g/d) 0·209 0·074 0·195 0·084 0·208 0·061 0·178 0·314 0·005 0·964 –0·024 0·827 0·002 0·986 –0·003 0·983
* Model 1: adjusted for sex, age, energy intake and maternal education level; model 2: model 1 additionally adjusted for body fat percentage; model 3: model 2 additionally adjusted
for abdominal adiposity; model 4: model 3 additionally adjusted for simple sugar intake.
† P<0·05.
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fried foods compared to their peers without hepatic steatosis(41).
However, in the present study children with hepatic steatosis
tended to consume more SSB compared to children without
hepatic steatosis, which is consistent with the association
between SSB consumption and NAFLD(10). Our observations
suggest that cereal intake may be protective against hepatic
steatosis development. On the contrary, Georgoulis et al.(42)
reported that refined grains were associated with higher like-
lihood of having NAFLD in adults, whereas whole grain con-
sumption favourably affected clinical characteristics of
participants with NAFLD as a result of being rich in fibre and
having lower glycaemic index. Unfortunately, due to the
infrequent intake of whole grains by children from the PRE-
DIKID study, we could not examine the influence of whole
cereals on hepatic health. On the other hand, in disagreement
with other studies in which whole cereal intake was inversely
associated with insulin resistance among adolescents(43), no
association was found between cereal intake and HOMA-IR in
overweight/obese children.
We observed that 39·8 and 65·5% of the children consumed
SSB and DDS, respectively (data not shown). Moreover, we
found a positive association between SSB consumption and
sugar in SSB and hepatic fat content regardless of sex, age,
energy intake, maternal educational level, body fat percentage,
abdominal obesity and total simple sugar intake. Of note, while
in the USA SSB are primarily sweetened with high fructose maize
syrup, in Europe sucrose is commonly used as the main sweet-
ener(44), which is a disaccharide composed of fructose and glu-
cose. Although several studies report the association of both
fructose(45) and SSB consumption(46,47) with adiposity and car-
diometabolic risk factors in adults and adolescents, few studies
focused on children to date. Furthermore, to the best of our
knowledge, this is the first study examining the influence of SSB
consumption on hepatic fat content in overweight/obese chil-
dren. Interestingly, neither SSB nor sugar from SSB was asso-
ciated with insulin resistance. In addition, based on the fact that
impaired insulin signalling originated by dysfunctional adipose
tissue induces insulin resistance, insulin resistance might be a
secondary effect of excess hepatic fat. Despite the lack of the
association in our study, other authors reported that daily intake
of SSB was associated with increased HOMA-IR in adoles-
cents(48). The possible mechanism of how fructose can induce
NAFLD has largely been studied in animal models. Briefly,
fructose is absorbed from the intestine into the portal vein and
goes directly to the liver, where it stimulates de novo lipogenesis
by promoting hepatic lipid accumulation(40,46), which may
explain NAFLD development. Nonetheless, not only fructose but
also sucrose-containing beverages have been shown to increase
hepatic fat as well as visceral and muscle fat and TAG(49).
In contrast, DDS consumption was not significantly asso-
ciated with hepatic fat content and insulin resistance in our
sample of overweight/obese children. This finding is in line
with previous studies suggesting that dairy fat intake as well as
other nutrients like Ca (which are mostly present in DDS, but
not in SSB) could be protective against hepatic fat accumulation
in adults(50) and abdominal adiposity in female adolescents(51).
In addition, the fact that DDS are commonly consumed with a
meal, whereas people tend to drink SSB between meals, could
also explain the influence on these outcomes. Accordingly,
previous studies reported that snacking promotes liver fat
accumulation(52,53). As a consequence of the rise of SSB con-
sumption in children, initiatives such as the implementation of
SSB-associated tax in several countries have been carried out to
prevent obesity and related comorbidities. The purchases of
SSB decreased after Mexico implemented a tax, so that this
seems to be a successful intervention from global policies(54).
Strengths and limitations
The use of MRI to measure hepatic fat content should be con-
sidered as study strength for its accuracy, while ultrasonography
is used in most of the other studies. Moreover, detailed nutri-
tional composition information of SSB and DDS was obtained
by analysing the labels of products brands. However, the cur-
rent study also has some limitations. These findings should be
analysed carefully due to its cross-sectional design and, there-
fore, prospective studies are needed since experimental evi-
dence would strengthen these cross-section observations.
Conclusions
The main findings in the present study suggest that cereal intake
seems to be associated with lower liver fat content, whereas
SSB consumption and sugar from SSB might increase hepatic fat
content among overweight/obese children. In contrast, neither
DDS consumption nor sugar from DDS seems to modulate
cardiometabolic risk factors, and last but not least, no associa-
tion was found between dietary intake and insulin resistance in
children with excess adiposity. Our results suggest that healthy
lifestyle intervention programs are needed to improve dietary
habits as well as to increase the awareness of the detrimental
effects of SSB consumption early in life.
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